SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laserscope (NASDAQ LSCP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dylan murphy who wrote (309)2/22/2005 11:45:36 AM
From: Dick Martin   of 314
 
Laserscope Schedules 2004 Fourth Quarter and Year-End Earnings Release and Conference Call
Tuesday February 22, 7:00 am ET

SAN JOSE, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Laserscope (Nasdaq: LSCP - News), a pioneer in the development and commercialization of medical lasers and advanced fiber-optic devices, will announce its 2004 fourth quarter and year-end results, for the period ended December 31, 2004, on Thursday, March 3, 2005 before the open of the market. Management of Laserscope will hold a conference call that morning at 8:00 a.m. PT/11:00 a.m. ET to discuss results for the quarter and year-end. To participate in the call, please dial 800-218-8862 (303-262-2142 for international callers) at least five minutes prior to the start time.

Investors will also have the opportunity to listen to the conference call live on the Internet through Laserscope's website at www.laserscope.com or at www.fulldisclosure.com. Investors should go to either website a few minutes early, as it may be necessary to download audio software to access the conference call.

A replay of the call will be available through Thursday, March 10, 2005 by dialing 800-405-2236 (303-590-3000 for international callers), passcode 11024579. A replay of the webcast will also be available at Laserscope's website.

About Laserscope

Laserscope designs, manufactures, sells and services on a worldwide basis an advanced line of medical laser systems and related energy delivery devices for the office, outpatient surgical center, and hospital markets. More information about Laserscope can be found on the Company's web site at www.laserscope.com.

Except for historical information presented, the matters discussed in this announcement may contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. These risks are detailed from time to time in the Company's public disclosure filings with the U.S. Securities and Exchange Commission (SEC). Copies of Laserscope's public disclosure filings with the SEC, including the most recent Annual Report on Form 10-K and the most recent quarterly reports on Forms 10-Q are available upon request from its Investor Relations Department.

At Laserscope:
Eric Reuter, President & CEO
Dennis LaLumandiere, CFO
(408) 943-0636

At Financial Relations Board:
Tricia Ross, Investor/Analyst Contact
(617) 520-7064
Laurie Berman, General Inquiries
(310) 854-8315
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext